Emmessar Biotech & Nutrition Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 3.16 million compared to INR 1.46 million a year ago. Revenue was INR 7.32 million compared to INR 8.52 million a year ago.

Net income was INR 1.97 million compared to INR 0.347 million a year ago. Basic earnings per share from continuing operations was INR 0.38 compared to INR 0.05 a year ago. Diluted earnings per share from continuing operations was INR 0.38 compared to INR 0.05 a year ago.